This was done by targeting cell surface genes in a syngeneic MLL/AF9AML murine model and demonstrating that C-X-C chemokine receptor type 4 (CXCR4) was critical in the regulation for AML cell growth and survival. Here, KMT2A is linked to acute myeloid leukemia.